Jaafar Bennouna

机构：Institut de Cancérologie de l'Ouest · ORCID：0000-0002-5034-1108

发表论文 555 篇 · 总被引 34016 次 · h-index 68

代表论文

• Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer (2024 · New England Journal of Medicine · 被引 267)
• Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study (2024 · Journal of Clinical Oncology · 被引 226)
• Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study (2024 · Journal of Clinical Oncology · 被引 130)
• Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial (2025 · Nature Medicine · 被引 41)
• Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials (2025 · Journal of Clinical Oncology · 被引 24)
• Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study (2024 · Lung Cancer · 被引 16)